Muscle Research Articles & Analysis
3 news found
The development of ZT-01 for T2D will be supported, in part, by advisory services and up to $415,000 in non-dilutive research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). ...
The development of ZT-01 for T2D will be supported, in part, by advisory services and up to $415,000 in non-dilutive research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). ...
Zucara Therapeutics will match the funding with an additional $85,000 in cash and in-kind contributions, including scientific input, to advance this research. Zucara’s lead drug candidate “ZT-01” is moving towards Phase 1 clinical trials in patients with T1D later this year, after demonstrating efficacy and safety validated in multiple preclinical models of ...